Bay Colony Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.85M Buy
15,152
+331
+2% +$77.1K 0.43% 49
2026
Q1
$3.62M Sell
14,821
-674
-4% -$157K 0.44% 48
2025
Q4
$3.21M Sell
15,495
-422
-3% -$83.5K 0.38% 51
2025
Q3
$2.95M Sell
15,917
-354
-2% -$60.6K 0.35% 58
2025
Q2
$2.49M Buy
16,271
+473
+3% +$72.7K 0.34% 62
2025
Q1
$2.59M Sell
15,798
-309
-2% -$48.3K 0.39% 55
2024
Q4
$2.33M Sell
16,107
-313
-2% -$48.5K 0.35% 65
2024
Q3
$2.66M Buy
16,420
+56
+0.3% +$8.92K 0.4% 51
2024
Q2
$2.39M Sell
16,364
-6,377
-28% -$948K 0.4% 52
2024
Q1
$3.6M Buy
22,741
+1,197
+6% +$191K 0.63% 35
2023
Q4
$3.38M Buy
21,544
+5,793
+37% +$888K 0.66% 33
2023
Q3
$2.45M Buy
15,751
+2,034
+15% +$336K 0.59% 37
2023
Q2
$2.27M Buy
13,717
+75
+0.5% +$12.1K 0.55% 41
2023
Q1
$2.09M Sell
13,642
-6,953
-34% -$1.12M 0.55% 42
2022
Q4
$3.64M Sell
20,595
-211
-1% -$36.4K 0.96% 20
2022
Q3
$3.4M Sell
20,806
-1,602
-7% -$271K 1.01% 16
2022
Q2
$3.91M Buy
22,408
+1,634
+8% +$291K 1% 17
2022
Q1
$3.68M Buy
20,774
+2,573
+14% +$438K 0.88% 20
2021
Q4
$3.11M Sell
18,201
-116
-0.6% -$19K 0.89% 18
2021
Q3
$2.96M Buy
18,317
+880
+5% +$150K 0.97% 11
2021
Q2
$2.87M Buy
17,437
+984
+6% +$163K 0.96% 13
2021
Q1
$2.7M Buy
16,453
+5,224
+47% +$845K 1.03% 9
2020
Q4
$1.77M Buy
11,229
+242
+2% +$35.7K 0.94% 16
2020
Q3
$1.64M Buy
10,987
+864
+9% +$128K 1.02% 19
2020
Q2
$1.42M Buy
10,123
+20
+0.2% +$2.92K 1.03% 20
2020
Q1
$1.32M Buy
10,103
+6,069
+150% +$861K 1.2% 13
2019
Q4
$598K Sell
4,034
-2,295
-36% -$311K 0.39% 92
2019
Q3
$819K Sell
6,329
-400
-6% -$52.7K 0.56% 56
2019
Q2
$937K Buy
6,729
+98
+1% +$13.6K 0.6% 37
2019
Q1
$921K Buy
6,631
+241
+4% +$32.3K 0.61% 39
2018
Q4
$825K Buy
6,390
+834
+15% +$116K 0.7% 31
2018
Q3
$768K Buy
5,556
+1,581
+40% +$210K 0.59% 46
2018
Q2
$482K Buy
+3,975
New +$496K 0.34% 74

Other funds holding JNJ

Bay Colony Advisors's JNJ Position: Q2 2026 in Review

Bay Colony Advisors increased its Johnson & Johnson (JNJ) stake by 2.2% in Q2 2026, buying an estimated $77.1K and bringing the position to 15,152 shares worth $3.85M. The position accounts for 0.43% of the portfolio, ranked #49.

Bay Colony Advisors first reported a position in JNJ in Q2 2018 and has held it in 33 quarters since. The position peaked at $3.91M in Q2 2022. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Bay Colony Advisors held 15,152 shares of Johnson & Johnson worth $3.85M as of Q2 2026.
  • Bay Colony Advisors bought 331 Johnson & Johnson shares in Q2 2026, an estimated $77.1K.
  • Johnson & Johnson made up 0.43% of Bay Colony Advisors's portfolio in Q2 2026, its #49 holding.
  • Bay Colony Advisors first reported a position in Johnson & Johnson in Q2 2018 and has held it in 33 quarters since.
  • Bay Colony Advisors's Johnson & Johnson position peaked at $3.91M in Q2 2022.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Bay Colony Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.